Skip to content
Lower risk Drug recall · FDA · Published July 24, 2018

West-Ward Doxycycline Tablets Recall: Failed Dissolution Specifications

West-Ward recalls 100mg doxycycline tablets with failed dissolution specs. Rx-only 500-count bottles manufactured in Eatontown, NJ. Check NDC# 0143-2112-05 and lot# 71545A for affected units.

🇺🇸 FDA recall #D-1025-2018DrugWest-Ward ›
Take action

Contact the company

Recalling firmWest-Ward Columbus Inc1809 Wilson Rd · Columbus, OH 43228-9579
✎ GovInfoNow plain-language explainer

West-Ward is recalling 100mg doxyc:ycline tablets that failed dissolution tests. This means the medication may not work properly when taken as directed, potentially reducing effectiveness. Read more at govinfonow.com/recall/39864-west-ward-doxycycline-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/39864-west-ward-doxycycline-tablets-recall-failed-dissolution-specifications · Updated October 6, 2026 · FDA enforcement record: FDA #D-1025-2018

Cite this page

“West-Ward Doxycycline Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39864-west-ward-doxycycline-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-1025-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1025-2018%22&limit=1).

West-Ward Columbus Inc recalled Doxycycline Hyclate Tablets, USP, 100 mg due to failed dissolution specifications, according to the FDA on July 24, 2018.

How to tell if you have it

  • Brand: West-Ward
  • Product: Doxycycline Hyclate Tablets, USP, 100 mg*
  • NDC#: 0143-2112-05
  • Lot#: 71545A
  • Expiry date: 07/19
  • Quantity: 29,048 bottles of 500-count

The hazard

The tablets failed dissolution specifications. The FDA classified this recall as Class II.

Context

GovInfoNow's records show West-Ward Columbus Inc has issued eight other recalls since May 19, 2016. Other recent recalls of similar products include Ascend Minocycline Tablets Recall (June 1, 2026), Inventia Chlorthalidone Recall (Sept. 3, 2026), and Inventia Healthcare Chlorthalidone Tablets Recall (June 5, 2026).

How to tell if you have this one

Check for the 500-count bottle labeled 'Doxycycline Hyclate Tablets, USP, 100 mg*'. Look for NDC# 0143-2112-05 and lot# 71545A on the packaging.

  • Brand
    West-Ward
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide in the USA.
  • NDC
    0143-2112-50, 0143-2112-05, 0143-2112-20
Recall numberProduct, codes & lotsQuantity
D-1024-2018Doxycycline Hyclate Tablets, USP, 100 mg*. 50-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-50.; Lot# 71545B, Expiry date: 01/1929,048 bottles (1,452,400 tablets)
D-1025-2018Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05.; Lot# 71545A, Expiry date: 07/1929048 500-count bottles (14,524,000 tablets)
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC number (0143-2112-05) and lot number (71545A) on the bottle label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Jul 24, 201812. FDA classified it Class II: Aug 2, 201823. Published in FDA’s Enforcement Report: Aug 8, 201834. FDA terminated the recall: Apr 29, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1025-2018 (July 24, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1025-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA